Clinical Trial Update: Clinical Outcomes Related to Cardiac Resynchronization Therapy Deactivation of Super Responders [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update reporting outcomes after deactivating cardiac resynchronization therapy in super-responders with cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy

Snippet

Sponsor: Yuksek Ihtisas Hospital | Conditions: Cardiomyopathy | Phase 2, Phase 3 | Status: COMPLETED